{
    "2019-02-21": [
        [
            {
                "time": "2023-02-15",
                "original_text": "GILD or ABBV: Which Is Expected to Report Faster EPS Growth?",
                "features": {
                    "keywords": [
                        "GILD",
                        "ABBV",
                        "EPS Growth"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-02-15",
                "original_text": "AbbVie Declares Quarterly Dividend",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Quarterly Dividend"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-02-15",
                "original_text": "GILD or ABBV: Which Is Expected to Report Faster Revenue Growth?",
                "features": {
                    "keywords": [
                        "GILD",
                        "ABBV",
                        "Revenue Growth"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-02-15",
                "original_text": "What Analysts Are Recommending for GILD and ABBV in February",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommendations",
                        "GILD",
                        "ABBV"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-02-15",
                "original_text": "The Daily Biotech Pulse: Genomic Health Earnings, AbbVie's Humira Approved For Another Indication In Japan",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Genomic Health",
                        "AbbVie",
                        "Humira",
                        "Approval",
                        "Japan"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-02-15",
                "original_text": "Waltham biotech Morphic signs $725M partnership with Janssen",
                "features": {
                    "keywords": [
                        "Waltham",
                        "Morphic",
                        "Partnership",
                        "Janssen",
                        "$725M"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}